Furthermore, it was also found that the number of tumor-infiltrating CD3+, CD4+, and CD8+ lymphocytes was slightly increased in stage I lung adenocarcinomas compared to that in the adjacent normal lung tissues, but it was significantly reduced in stage II and III lung adenocarcinomas. This evidence concerns the gene CD4 and lung adenocarcinoma.